Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Vor Biopharma Announces Pricing of Initial Public Offering
Vor BiopharmaFebruary 5, 2021 GMT
CAMBRIDGE, Mass., Feb. 05, 2021 (GLOBE NEWSWIRE) Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced the pricing of its initial public offering of 9,828,017 shares of its common stock at a price to the public of $18.00 per share. The gross proceeds to Vor from the offering, before deducting the underwriting discounts and commissions and other offering expenses payable by Vor, are expected to be approximately $176.9 million. In addition, Vor has granted the underwriters a 30-day option to purchase up to an additional 1,474,202 shares of its common stock at the initial public offering price, less the underwriting discounts and commissions. All of the shares
Angion Biomedica Corp. Announces Pricing of Initial Public Offering of Common Stock and Concurrent Private Placement
UNIONDALE, N.Y., Feb. 05, 2021 (GLOBE NEWSWIRE) Angion Biomedica Corp. (Angion) (NASDAQ:ANGN), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, today announced the pricing of its initial public offering on February 4, 2021 of 5,000,000 shares of common stock at a public offering price of $16.00 per share, for gross proceeds of $80,000,000 million, before deducting the underwriting discounts and commissions and offering expenses. All of the shares of common stock are being offered by Angion. Angion has also granted the underwriters a 30-day option to purchase from Angion up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions. Angion’s common sto
Share:
ST. LOUIS, Feb. 03, 2021 (GLOBE NEWSWIRE) Stifel Financial Corp. (NYSE:SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.15 per share, payable March 15, 2021, to shareholders of record at the close of business on March 1, 2021. As previously announced on November 11, 2020, this represents a 32% increase in our quarterly common stock dividend.
The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series A (the Series A Preferred Stock ), 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the Series B Preferred Stock ), and 6.125% Non-Cumulative Perpetual Preferred Stock, Series C (the Series C Preferred Stock ). The declared cash dividend on the Series A Preferred Stock, the Series B Preferred Stock, and Series C Preferred Stock is for the period from December 15, 2020, up to, but excluding March 15, 2021. The d
Press release content from Business Wire. The AP news staff was not involved in its creation.
Noble Rock Acquisition Corporation Announces Pricing of Upsized $210 Million Initial Public Offering
February 2, 2021 GMT
WILMINGTON, Del. (BUSINESS WIRE) Feb 1, 2021
Noble Rock Acquisition Corporation (the “Company”) announced today that it priced its initial public offering of 21,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “NRACU” beginning February 2 nd, 2021. Each unit consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and redeemable warrants are expected to be listed on Nasdaq under the symbols “NRAC” and
Stifel Reports Record Fourth Quarter and Full-Year Results
25
th consecutive year of record net revenues of $3.8 billion, an increase of 12.4% compared with 2019.
Quarterly record net revenues of $1.1 billion, an increase of 20.0% over the third quarter of 2020.
Record quarterly net income available to common shareholders of $180.8 million, or $1.55 per diluted common share.
(1)
Record non-GAAP net income available to common shareholders of $195.1 million, or $1.67 per diluted common share.
(1)
Annualized return on average tangible common shareholders’ equity
(2) was 30.8%.
(2) was 33.3%.
Increasing quarterly dividend by approximately 32% to $0.15 per common share starting in first quarter of 2021.
ST. LOUIS, Jan. 29, 2021 (GLOBE NEWSWIRE) Stifel Financial Corp. (NYSE: SF) today reported record net income available to common shareholders of $180.8 million, or $1.55 per diluted common share